Encouraged by the results from SNc modeling that the dysregulated CaV1.3, Ca2+ influx and pacemaking could be corrected back to normal, we expect CMI and its therapeutic potentials to manifest in diverse pathophysiology including CaV1 channelopathies. The gene discussed is CACNA1D; the disease is channelopathy.